ELOVL4

Chr 6ARAD

ELOVL fatty acid elongase 4

Also known as: ADMD, CT118, ISQMR, SCA34, STGD2, STGD3

The protein catalyzes the rate-limiting step in very long-chain fatty acid elongation, synthesizing saturated and polyunsaturated fatty acids that serve as precursors for membrane lipids critical in early brain and skin development. Mutations cause autosomal dominant Stargardt disease 3 (retinal dystrophy), autosomal recessive spinocerebellar ataxia 34, and autosomal recessive ichthyosis with spastic quadriplegia and intellectual disability. The gene is highly constrained against loss-of-function variants, reflecting its essential role in neurodevelopment and retinal function.

OMIMResearchSummary from RefSeq, OMIM, UniProt
LOFmechanismAR/ADLOEUF 0.413 OMIM phenotypes
Clinical SummaryELOVL4
🧬
Gene-Disease Validity (ClinGen)
ELOVL4-related maculopathy · ADDefinitive

Definitive — sufficient evidence for diagnostic panels

Population Constraint (gnomAD)
Moderately constrained gene (pLI 0.83) — some intolerance to loss-of-function variants.
📋
ClinVar Variants
42 unique Pathogenic / Likely Pathogenic· 187 VUS of 379 total submissions
💊
Clinical Trials
1 active or recruiting trial — potential therapeutic options may be available

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Moderate LoF intolerance
LoF Constraint
0.41LOEUF
pLI 0.832
Z-score 3.41
OE 0.16 (0.070.41)
Moderately constrained

More LoF-intolerant than ~75% of genes

Missense Constraint
1.19Z-score
OE missense 0.74 (0.640.86)
126 obs / 169.4 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios
LoF OE0.16 (0.070.41)
00.351.4
Missense OE0.74 (0.640.86)
00.61.4
Synonymous OE1.05
01.21.6
LoF obs/exp: 3 / 19.1Missense obs/exp: 126 / 169.4Syn Z: -0.28
Curated Mechanism (G2P)Gene2Phenotype (DDG2P) ↗
definitiveELOVL4-related ichthyosis, spastic quadriplegia, and intellectual developmental disorderLOFAR
definitiveELOVL4-related Stargardt diseaseLOFAD
DN
0.6065th %ile
GOF
0.5954th %ile
LOF
0.48top 25%

This gene has evidence for multiple mechanisms of pathogenicity (loss-of-function, dominant-negative and gain-of-function). The Badonyi & Marsh model scores dominant-negative highest among its predictions, but genomic evidence (constraint, ClinVar variant spectrum, and literature) most strongly supports loss-of-function (haploinsufficiency). Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

LOF50% of P/LP variants are LoF · LOEUF 0.41
DN1 literature citation
GOF1 literature citation

Literature Evidence

DNPathogenic mutations found in the ELOVL4 gene result in altered trafficking of the protein and behave with a dominant negative effect.PMID:20096366
GOFWe showed that L168F and W246G mutants were capable of VLC-PUFA biosynthesis. W246G synthesized and accumulated 32:6n3, while L168F exhibited gain of function in VLC-PUFA biosynthesis as it made 38:5n3, which we did not detect in WT-ELOVL4 or W246G-expressing cells.PMID:36464075

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312. Mechanism ranking also informed by gnomAD constraint, ClinVar, and ClinGen data.

ClinVar Variant Classifications

379 submitted variants in ClinVar

Classification Summary

Pathogenic31
Likely Pathogenic11
VUS187
Likely Benign103
Benign34
Conflicting11
31
Pathogenic
11
Likely Pathogenic
187
VUS
103
Likely Benign
34
Benign
11
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
14
2
15
0
31
Likely Pathogenic
7
3
1
0
11
VUS
3
132
50
2
187
Likely Benign
0
3
37
63
103
Benign
0
1
33
0
34
Conflicting
11
Total2414113665377

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

ELOVL4 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

3D Protein StructureAlphaFold
Clinical Literature
Open Research Assistant →